首页> 外文期刊>Journal of Medicinal Chemistry >bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein.
【24h】

bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein.

机译:双(2-(酰基氨基)苯基)二硫化物,2-(酰基氨基)苯硫醇和S-(2-(酰基氨基)苯基)链烷硫醇盐作为胆固醇酯转移蛋白的新型抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of bis(2-(acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, S-(2-(acylamino)phenyl) alkanethioates, and related compounds were synthesized, and their inhibitory effect on cholesteryl ester transfer protein activity in human plasma was evaluated. This study elucidated the structural requirements for inhibitory activity and determined that the optimum compound was S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate (27) (JTT-705). This compound achieved 50% inhibition of CETP activity in human plasma at a concentration of 9 microM and 95% inhibition of CETP activity in male Japanese white rabbits at an oral dose of 30 mg/kg. It increased the plasma HDL cholesterol level by 27% and 54%, respectively, when given at oral doses of 30 or 100 mg/kg once a day for 3 days to male Japanese white rabbits.
机译:合成了一系列的双(2-(酰基氨基)苯基)二硫化物,2-(酰基氨基)苯硫醇,S-(2-(酰基氨基)苯基)链烷硫醇及其相关化合物,它们对胆甾醇酯转移蛋白活性具有抑制作用。评价人血浆。这项研究阐明了抑制活性的结构要求,并确定最佳化合物为S-(2-(((1-(2-(乙基乙基丁基)环己烷)羰基氨基)苯基)2-甲基丙硫醇酯(27)(JTT-705)。在口服剂量为30 mg / kg时,该化合物在9 microM的浓度下对人血浆的CETP活性具有50%的抑制作用,在雄性日本白兔中的CETP活性具有95%的抑制作用。当每天给雄性日本白兔口服30或100 mg / kg剂量,持续3天时,血浆HDL胆固醇水平分别增加27%和54%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号